# Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial

> **NCT03058822** · PHASE1 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 5 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BMS-931699

## Key facts

- **NCT ID:** NCT03058822
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-25
- **Primary completion:** 2017-03-30
- **Final completion:** 2017-03-30
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Business objectives have changed
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03058822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03058822, "Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03058822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*